Search This Blog

Wednesday, August 8, 2018

Wave Life Sciences Duchenne muscular dystrophy treatment gets orphan status


Wave Life Sciences’ treatment of Duchenne muscular dystrophy treatment was granted FDA orphan status, according to a post to the agency’s website
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)